{"id":9047,"date":"2024-07-01T15:09:00","date_gmt":"2024-07-01T13:09:00","guid":{"rendered":"https:\/\/czecrin.cz\/project\/kh-infuro\/"},"modified":"2026-01-06T09:38:31","modified_gmt":"2026-01-06T08:38:31","slug":"kh-infuro","status":"publish","type":"project","link":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/","title":{"rendered":"CT INFURO"},"content":{"rendered":"\n<h3 class=\"wp-block-heading has-text-align-center\">CLINICAL TRIAL OF INFURO<\/h3>\n\n<hr class=\"wp-block-separator has-text-color has-black-color has-alpha-channel-opacity has-black-background-color has-background\"\/>\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"has-text-align-center\">INFURO is designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea. Dyspnea is one of the most common symptoms in internal medicine. It has an adverse effect on patients&#8217; quality of life and is also an independent predictor of mortality in patients with cardiovascular and respiratory diseases. However, there is still a lack of safe and effective therapy for causally uncontrollable dyspnoea, particularly in palliative care.<\/p>\n\n<p class=\"has-text-align-center\">The sponsor of the clinical trial is the University Hospital Hradec Kr\u00e1lov\u00e9, where the study under the leadership of Assoc. MUDr. Vladim\u00edr Koblizek, Ph.D. and his colleagues is being conducted.  <\/p>\n\n<h6 class=\"wp-block-heading has-text-align-center\">RECRUITMENT OF PATIENTS<\/h6>\n\n<p class=\"has-text-align-center\">The clinical trial was initiated and started in February 2024, currently 17 patients are enrolled out of 102 planned.<\/p>\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-text-align-center\">Important links to the project<\/h2>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06252454?intr=furosemide&amp;locStr=Czech%20Republic&amp;country=Czechia&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">KH registration at clinicaltrials.gov<\/a><\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong><a href=\"https:\/\/redcap.czecrin.cz\/index.php?action=myprojects\" target=\"_blank\" rel=\"noreferrer noopener\">Access to the REDCap database (for examiners)<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-text-align-center\">Project documents<\/h2>\n\n<hr class=\"wp-block-separator has-text-color has-black-color has-alpha-channel-opacity has-black-background-color has-background\"\/>\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong><a href=\"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/04\/INFURO_Synopse-protokolu_verze-2.1_12.7.2023.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Protocol summary (synopsis)<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h5 class=\"wp-block-heading has-text-align-center\">Contact<\/h5>\n\n<p class=\"has-text-align-center has-medium-font-size\">Study sponsor:<br\/>Hradec Kr\u00e1lov\u00e9 University Hospital | doc. MUDr. Vladim\u00edr Koblizek, Ph.D.  <\/p>\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"has-text-align-center has-medium-font-size\">Project Manager:<br\/>Ing. Karol\u00edna Grodov\u00e1 | <a href=\"mailto:karolina.grodova@med.muni.cz\">karolina.grodova@med.muni.cz<\/a> and MUDr. Michal \u0160varc <\/p>\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<ul class=\"wp-block-social-links aligncenter is-layout-flex wp-block-social-links-is-layout-flex\"><li class=\"wp-social-link wp-social-link-x  wp-block-social-link\"><a href=\"https:\/\/twitter.com\/intent\/tweet?hashtags=remed%2Cczecrin%2Cclinicaltrials&#038;original_referer=https%3A%2F%2Fczecrin.cz%2F&#038;ref_src=twsrc%5Etfw%7Ctwcamp%5Ebuttonembed%7Ctwterm%5Eshare%7Ctwgr%5E&#038;related=%40czecrin&#038;text=KH%20INFURO%20-%20Czecrin&#038;url=https%3A%2F%2Fczecrin.cz%2Fprojekty%2Fkh-infuro%2F\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M13.982 10.622 20.54 3h-1.554l-5.693 6.618L8.745 3H3.5l6.876 10.007L3.5 21h1.554l6.012-6.989L15.868 21h5.245l-7.131-10.378Zm-2.128 2.474-.697-.997-5.543-7.93H8l4.474 6.4.697.996 5.815 8.318h-2.387l-4.745-6.787Z\" \/><\/svg><span class=\"wp-block-social-link-label screen-reader-text\">X<\/span><\/a><\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL TRIAL OF INFURO INFURO is designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea. Dyspnea is one of the most common symptoms in internal medicine. It has an adverse effect on patients&#8217; quality of life and is also [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[147,146],"project_tag":[151,150],"class_list":["post-9047","project","type-project","status-publish","hentry","project_category-national-research-projects","project_category-ongoing-clinical-trials","project_tag-internal-medicine","project_tag-phase-ii"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CT INFURO &#8226; CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu<\/title>\n<meta name=\"description\" content=\"Designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CT INFURO &#8226; CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu\" \/>\n<meta property=\"og:description\" content=\"Designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/\" \/>\n<meta property=\"og:site_name\" content=\"CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/czecrin\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-06T08:38:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/czecrin__zakladni-logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1733\" \/>\n\t<meta property=\"og:image:height\" content=\"952\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/\",\"url\":\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/\",\"name\":\"CT INFURO &#8226; CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu\",\"isPartOf\":{\"@id\":\"https:\/\/czecrin.cz\/en\/#website\"},\"datePublished\":\"2024-07-01T13:09:00+00:00\",\"dateModified\":\"2026-01-06T08:38:31+00:00\",\"description\":\"Designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea.\",\"breadcrumb\":{\"@id\":\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Dom\u016f\",\"item\":\"https:\/\/czecrin.cz\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/czecrin.cz\/en\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CT INFURO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/czecrin.cz\/en\/#website\",\"url\":\"https:\/\/czecrin.cz\/en\/\",\"name\":\"CZECRIN\",\"description\":\"\u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu\",\"publisher\":{\"@id\":\"https:\/\/czecrin.cz\/en\/#organization\"},\"alternateName\":\"\u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/czecrin.cz\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/czecrin.cz\/en\/#organization\",\"name\":\"VVI CZECRIN\",\"alternateName\":\"\u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu\",\"url\":\"https:\/\/czecrin.cz\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/czecrin.cz\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/czecrin__zakladni-logo-1.png\",\"contentUrl\":\"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/czecrin__zakladni-logo-1.png\",\"width\":1733,\"height\":952,\"caption\":\"VVI CZECRIN\"},\"image\":{\"@id\":\"https:\/\/czecrin.cz\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/czecrin\",\"https:\/\/www.linkedin.com\/company\/czecrin\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CT INFURO &#8226; CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","description":"Designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/","og_locale":"en_US","og_type":"article","og_title":"CT INFURO &#8226; CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","og_description":"Designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea.","og_url":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/","og_site_name":"CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","article_publisher":"https:\/\/www.facebook.com\/czecrin","article_modified_time":"2026-01-06T08:38:31+00:00","og_image":[{"width":1733,"height":952,"url":"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/czecrin__zakladni-logo-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/","url":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/","name":"CT INFURO &#8226; CZECRIN - \u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","isPartOf":{"@id":"https:\/\/czecrin.cz\/en\/#website"},"datePublished":"2024-07-01T13:09:00+00:00","dateModified":"2026-01-06T08:38:31+00:00","description":"Designed as a monocentric, prospective, randomized, double-blind, cross-over Phase II clinical trial to test the safety and tolerability of furosemide inhalation in patients with dyspnea.","breadcrumb":{"@id":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/czecrin.cz\/en\/project\/kh-infuro\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/czecrin.cz\/en\/project\/kh-infuro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Dom\u016f","item":"https:\/\/czecrin.cz\/en\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/czecrin.cz\/en\/project\/"},{"@type":"ListItem","position":3,"name":"CT INFURO"}]},{"@type":"WebSite","@id":"https:\/\/czecrin.cz\/en\/#website","url":"https:\/\/czecrin.cz\/en\/","name":"CZECRIN","description":"\u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","publisher":{"@id":"https:\/\/czecrin.cz\/en\/#organization"},"alternateName":"\u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/czecrin.cz\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/czecrin.cz\/en\/#organization","name":"VVI CZECRIN","alternateName":"\u010cesk\u00e1 n\u00e1rodn\u00ed s\u00ed\u0165 pro podporu klinick\u00e9ho v\u00fdzkumu","url":"https:\/\/czecrin.cz\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/czecrin.cz\/en\/#\/schema\/logo\/image\/","url":"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/czecrin__zakladni-logo-1.png","contentUrl":"https:\/\/czecrin.cz\/wp-content\/uploads\/2025\/02\/czecrin__zakladni-logo-1.png","width":1733,"height":952,"caption":"VVI CZECRIN"},"image":{"@id":"https:\/\/czecrin.cz\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/czecrin","https:\/\/www.linkedin.com\/company\/czecrin\/"]}]}},"_links":{"self":[{"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/project\/9047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/comments?post=9047"}],"version-history":[{"count":2,"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/project\/9047\/revisions"}],"predecessor-version":[{"id":9292,"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/project\/9047\/revisions\/9292"}],"wp:attachment":[{"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/media?parent=9047"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/project_category?post=9047"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/czecrin.cz\/en\/wp-json\/wp\/v2\/project_tag?post=9047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}